Vilanto- F™
Therapeutic Segment:
Anti-Asthmatic +COPD
Generic Name:
Fluticasone Furoate + Vilanterol
Indication
DPI Capsules
- 100mcg + 62.5mcg
- 200mcg + 62.5mcg
Vilanto-F DPI capsules are indicated for:
• The maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults and adolescents aged 12 years and older.
• The maintenance treatment of asthma in patients aged 12 years and older.